Tower Research Capital LLC (Trc) Aura Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,268 shares of AURA stock, worth $25,138. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,268
Previous 3,102
37.59%
Holding current value
$25,138
Previous $25,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
40.4MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$40.8 Million12.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$28.7 Million0.06% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.32MShares$19.6 Million0.67% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$17.9 Million4.98% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$17.7 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $172M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...